ZA200403675B - Antibiotics GE 81112 factors, A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof. - Google Patents
Antibiotics GE 81112 factors, A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof.Info
- Publication number
- ZA200403675B ZA200403675B ZA200403675A ZA200403675A ZA200403675B ZA 200403675 B ZA200403675 B ZA 200403675B ZA 200403675 A ZA200403675 A ZA 200403675A ZA 200403675 A ZA200403675 A ZA 200403675A ZA 200403675 B ZA200403675 B ZA 200403675B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- pharmaceutically acceptable
- acceptable salts
- antibiotics
- factors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
The invention relates to an antibiotic substances of microbial origin, arbitrarily denominated antibiotic GE 81112 factor A, factor B1 and factor B, which is produced by fermentation of Streptomyces sp. DSMZ 14386, the pharmaceutically acceptable salts and compositions thereof, and their use as an antibacterial agent having inhibitory activity versus susceptible microbes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01128204 | 2001-11-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200403675B true ZA200403675B (en) | 2005-05-13 |
Family
ID=8179366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200403675A ZA200403675B (en) | 2001-11-28 | 2004-05-13 | Antibiotics GE 81112 factors, A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof. |
Country Status (22)
Country | Link |
---|---|
US (3) | US7407654B2 (en) |
EP (1) | EP1448784B1 (en) |
JP (1) | JP4452505B2 (en) |
KR (1) | KR20040099257A (en) |
CN (1) | CN1596312A (en) |
AT (1) | ATE390490T1 (en) |
AU (2) | AU2002365433A1 (en) |
BR (1) | BR0214494A (en) |
CA (1) | CA2468400A1 (en) |
DE (1) | DE60225834T2 (en) |
ES (1) | ES2299635T3 (en) |
HR (1) | HRP20040471A2 (en) |
HU (1) | HUP0402383A3 (en) |
IL (1) | IL161896A0 (en) |
MX (1) | MXPA04005032A (en) |
NO (1) | NO20042181L (en) |
NZ (1) | NZ533732A (en) |
PL (1) | PL370451A1 (en) |
RU (1) | RU2004119432A (en) |
WO (1) | WO2003046192A1 (en) |
YU (1) | YU46804A (en) |
ZA (1) | ZA200403675B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE390490T1 (en) * | 2001-11-28 | 2008-04-15 | Vicuron Pharm Inc | ANTIBIOTIC GE-81112 FACTORS A, B, B1, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS AND USES THEREOF |
US11744859B2 (en) | 2017-07-07 | 2023-09-05 | Epicentrx, Inc. | Compositions and methods for parenteral administration of therapeutic agents |
KR102408301B1 (en) * | 2020-03-16 | 2022-06-10 | 강원대학교산학협력단 | Novel Strain of Streptomyces sp. SBC-4 Having Anti-bacterial Activity, and Uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5043353A (en) * | 1989-10-10 | 1991-08-27 | Eli Lilly And Company | A80789 polyether antibiotic |
AU679202B2 (en) * | 1992-12-22 | 1997-06-26 | Gruppo Lepetit S.P.A. | Antibiotics GE 37468 A, B and C |
US5432193A (en) * | 1993-05-14 | 1995-07-11 | American Cyanamid Company | Antibiotic LL-D37187α |
US5426108A (en) | 1993-11-10 | 1995-06-20 | American Cyanamid Company | Antibiotic 31F508 ALPHA1, ALPHA2, BETA1 and BETA2 |
US5486630A (en) * | 1994-09-14 | 1996-01-23 | Cheil Foods & Chemicals Inc. | Legionella specific antibiotic |
ATE390490T1 (en) * | 2001-11-28 | 2008-04-15 | Vicuron Pharm Inc | ANTIBIOTIC GE-81112 FACTORS A, B, B1, PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS AND USES THEREOF |
-
2002
- 2002-10-04 AT AT02803759T patent/ATE390490T1/en not_active IP Right Cessation
- 2002-10-04 JP JP2003547624A patent/JP4452505B2/en not_active Expired - Fee Related
- 2002-10-04 CN CNA02823720XA patent/CN1596312A/en active Pending
- 2002-10-04 DE DE60225834T patent/DE60225834T2/en not_active Expired - Lifetime
- 2002-10-04 RU RU2004119432/13A patent/RU2004119432A/en not_active Application Discontinuation
- 2002-10-04 WO PCT/EP2002/011113 patent/WO2003046192A1/en active IP Right Grant
- 2002-10-04 IL IL16189602A patent/IL161896A0/en unknown
- 2002-10-04 MX MXPA04005032A patent/MXPA04005032A/en not_active Application Discontinuation
- 2002-10-04 AU AU2002365433A patent/AU2002365433A1/en not_active Abandoned
- 2002-10-04 EP EP02803759A patent/EP1448784B1/en not_active Expired - Lifetime
- 2002-10-04 US US10/496,009 patent/US7407654B2/en not_active Expired - Fee Related
- 2002-10-04 KR KR10-2004-7008079A patent/KR20040099257A/en not_active Application Discontinuation
- 2002-10-04 YU YU46804A patent/YU46804A/en unknown
- 2002-10-04 ES ES02803759T patent/ES2299635T3/en not_active Expired - Lifetime
- 2002-10-04 BR BR0214494-8A patent/BR0214494A/en not_active IP Right Cessation
- 2002-10-04 CA CA002468400A patent/CA2468400A1/en not_active Abandoned
- 2002-10-04 NZ NZ533732A patent/NZ533732A/en unknown
- 2002-10-04 HU HU0402383A patent/HUP0402383A3/en unknown
- 2002-10-04 PL PL02370451A patent/PL370451A1/en not_active Application Discontinuation
-
2004
- 2004-05-13 ZA ZA200403675A patent/ZA200403675B/en unknown
- 2004-05-26 NO NO20042181A patent/NO20042181L/en not_active Application Discontinuation
- 2004-05-27 HR HR20040471A patent/HRP20040471A2/en not_active Application Discontinuation
-
2008
- 2008-06-26 US US12/147,215 patent/US8007789B2/en not_active Expired - Fee Related
- 2008-12-08 AU AU2008255202A patent/AU2008255202A1/en not_active Abandoned
-
2011
- 2011-08-05 US US13/198,754 patent/US20110286996A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60225834D1 (en) | 2008-05-08 |
ES2299635T3 (en) | 2008-06-01 |
WO2003046192A1 (en) | 2003-06-05 |
EP1448784A1 (en) | 2004-08-25 |
US8007789B2 (en) | 2011-08-30 |
DE60225834T2 (en) | 2009-04-09 |
CN1596312A (en) | 2005-03-16 |
RU2004119432A (en) | 2006-01-10 |
IL161896A0 (en) | 2005-11-20 |
US7407654B2 (en) | 2008-08-05 |
EP1448784B1 (en) | 2008-03-26 |
YU46804A (en) | 2006-08-17 |
HUP0402383A3 (en) | 2008-03-28 |
ATE390490T1 (en) | 2008-04-15 |
HRP20040471A2 (en) | 2004-10-31 |
KR20040099257A (en) | 2004-11-26 |
HUP0402383A2 (en) | 2005-02-28 |
AU2008255202A1 (en) | 2009-01-08 |
AU2002365433A1 (en) | 2003-06-10 |
NZ533732A (en) | 2005-05-27 |
CA2468400A1 (en) | 2003-06-05 |
US20050020514A1 (en) | 2005-01-27 |
US20090023665A1 (en) | 2009-01-22 |
PL370451A1 (en) | 2005-05-30 |
BR0214494A (en) | 2004-10-19 |
US20110286996A1 (en) | 2011-11-24 |
JP4452505B2 (en) | 2010-04-21 |
MXPA04005032A (en) | 2004-08-11 |
JP2005510573A (en) | 2005-04-21 |
NO20042181L (en) | 2004-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005000878A8 (en) | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | |
CA2546625A1 (en) | Glycopeptide antibiotic derivatives | |
HRP20060275B1 (en) | 6-0-supstituted ketolides having antibacterial activity | |
AP2001002236A0 (en) | Macrolide antibiotics. | |
AU2002222296A1 (en) | Macrolide antibiotics | |
AU4562397A (en) | Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms | |
AU2119200A (en) | Medicament | |
IL187551A0 (en) | Antimicrobial capuramycin derivatives and pharmaceutical compositions containing the same | |
RS20050931A (en) | Novel lincomycin derivatives possessing antimicro bial activity | |
MXPA06000691A (en) | Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof. | |
WO2002017854A3 (en) | Cephalosporin antibiotics and prodrugs thereof | |
WO2004016632A8 (en) | Lincomycin derivatives possessing antibacterial activity | |
HRP20040471A2 (en) | Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof | |
MY128739A (en) | Compositions and methods for treating bacterial infections | |
AU4785896A (en) | Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics | |
WO2004098500A3 (en) | CARBACEPHEM ss-LACTAM ANTIBIOTICS | |
AU2001256708A1 (en) | Method of screening compound having antimicrobial activity on pathogenic microorganism infecting organism having acquired immune mechanism by using organism having natural immune mechanism alone, and method of evaluating the antimicrobial activity by using organism having natural | |
WO2000010998A3 (en) | Pyridone antibiotic with improved safety profile | |
AU2001286741A1 (en) | Methods and compositions for potentiating antibiotic action against persistent/tolerant pathogenic microorganisms | |
AU2002214197A1 (en) | Macrolides | |
EP1604660A4 (en) | Medicinal composition for treating infection with drug-resistant staphylococcus aureus | |
EP1439840A4 (en) | Monobactam antibacterial compounds and methods of use thereof | |
MXPA01012427A (en) | Antibiotics ge 23077, pharmaceutically acceptable salts and compositions, and use thereof. | |
AU2002360218A1 (en) | A METHOD OF TREATING BACTERIAL INFECTIONS USING GEMIFLOXACIN OR A SALT THEREOF AND A Beta -LACTAM ANTIBIOTIC | |
AU2003271022A1 (en) | Antibacterial compositions of n-acetyl-d-aminoglycosamine and antibiotics |